A comparison of Atrial Fibrillation Detection Strategies After Ischemic Stroke-A Retrospective Study.


Journal

Current problems in cardiology
ISSN: 1535-6280
Titre abrégé: Curr Probl Cardiol
Pays: Netherlands
ID NLM: 7701802

Informations de publication

Date de publication:
Mar 2023
Historique:
received: 13 11 2022
accepted: 15 11 2022
pubmed: 27 11 2022
medline: 1 2 2023
entrez: 26 11 2022
Statut: ppublish

Résumé

Objective of this retrospective study was to determine if long-term continuous cardiac monitoring with Implantable loop recorder (ILR) in patients with Cryptogenic strokes or TIA is superior at detecting Atrial Fibrillation (AF) than 30-day Event Monitor (EM) and 48-hour Holter Monitor (HM). Furthermore, we aimed to deduce if uncovering AF leads to lower risk of future ischemic strokes, or reduction in mortality. In 20%-30% cases, the cause of stroke remained unexplained after diagnostic workup which has led to coining of the term, Cryptogenic Stroke (CS). Undiagnosed AF is a prime suspect in CS, but guidelines do not recommend initiation of anticoagulation unless AF has formally been detected. IRB approved retrospective study included patients with at least 1 episode of ischemic stroke or TIA without identifiable cause and was monitored with either HM, EM or ILR to diagnose any undiscovered AF. All patients (n = 531) had at least 1 year, and up to 3 years, of follow-up after device placement. Chi-Squared analysis and Multivariable logistic regression demonstrated no statistically significant difference among 3 devices for detection of AF within 1 month of index stroke but a significant difference in AF detection was observed at 6, 12 and 24 months. Cox proportional hazard model showed device type had no significant impact on secondary outcomes: Subsequent ischemic stroke or TIA, Initiation of anticoagulation, Mortality and Incidence of major bleeding. Despite the superiority of AF detection by ILR, it is not superior to HM or EM in lowering the risk of subsequent stroke or TIA, or in reducing mortality.

Identifiants

pubmed: 36435267
pii: S0146-2806(22)00412-1
doi: 10.1016/j.cpcardiol.2022.101515
pii:
doi:

Substances chimiques

Anticoagulants 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Pagination

101515

Informations de copyright

Copyright © 2022 Elsevier Inc. All rights reserved.

Auteurs

Salman Salehin (S)

Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX. Electronic address: salmansalehin91@gmail.com.

Saleh Muhammad (S)

Department of Cardiology, University of Texas Medical Branch, Galveston, TX.

Peter Rasmussen (P)

Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX.

Steven Mai (S)

Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX.

Zaid Safder (Z)

Department of Internal Medicine, University of Texas Medical Branch, Galveston, TX.

Syed M Hasan (SM)

Department of Cardiology, University of Texas Medical Branch, Galveston, TX.

Hafiz A Ghani (HA)

Department of Pathology, University of Texas Medical Branch, Galveston, TX.

Yuanyi Zhang (Y)

Department of Biostatistics, University of Texas Medical Branch, Galveston, TX.

Shahran Salehin (S)

School of Medicine, Holy Family Red Crescent Medical College Hospital, Dhaka, Bangladesh.

Yong-Fang Kuo (YF)

Department of Biostatistics, University of Texas Medical Branch, Galveston, TX.

Khaled Chatila (K)

Department of Cardiology, University of Texas Medical Branch, Galveston, TX.

Wissam Khalife (W)

Department of Cardiology, University of Texas Medical Branch, Galveston, TX.

Asif Sewani (A)

Department of Cardiology, University of Texas Medical Branch, Galveston, TX.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH